PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer
- Status
- TERMINATED
- Phase
- N/A
Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study
- Status
- UNKNOWN
- Phase
- PHASE2
Prognostic Significance of Lymph Node Yield and Lymph Node Ratio Prospective Observational Study
- Status
- UNKNOWN
- Phase
- N/A
Pre- and Postoperative Nutrition in Head and Neck Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Physical Exercise for Patients Who Suffer From Weight Loss Due to Head and Neck Cancer Undergoing Medical Treatment
- Status
- COMPLETED
- Phase
- NA
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation
- Status
- COMPLETED
- Phase
- NA
PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study
- Status
- COMPLETED
- Phase
- NA
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
New MRI Biomarkers in Head and Neck Cancers
- Status
- RECRUITING
- Phase
- N/A
Evaluation of an Oral Care Programme for Head and Neck Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy
- Status
- TERMINATED
- Phase
- PHASE2
MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer
- Status
- TERMINATED
- Phase
- NA
Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously
- Status
- UNKNOWN
- Phase
- N/A